Drug Recall: Dabigatran Etexilate Capsules 150 mg by Ascend Laboratories
Ascend Laboratories is recalling 2,717 cartons of Dabigatran Etexilate Capsules, 150 mg, because stability testing found impurities above specification.
- Product
- DABIGATRAN ETEXILATE — DABIGATRAN ETEXILATE (DABIGATRAN ETEXILATE)
- Category
- Drug
- Distribution
- Distributed nationwide